
Uganda Battling Deadly Marburg Outbreak
A viral hemorrhagic fever is currently plaguing Uganda. We break down the current situation.
Although the
Marburg first found itself on our infectious diseases radar in 1967 because of a series of simultaneous outbreaks in laboratories in Marburg and Frankfurt Germany, as well as Belgrade, Serbia. Over 30 individuals became ill in these laboratory incidents. An epidemiological investigation found that the first few cases were a result of exposure to imported African green monkeys or their tissue during laboratory research. The virus is typically transmitted from animals to humans, and then spread between humans through direct contact with droplets of body fluids or contact with contaminated equipment, etc. Hospitals and immediate caregivers in the infected individual’s home can be sources of transmission.
The viral infection has an incubation period of 5 to 10 days and symptoms are usually fever, chills, headache, and myalgia. These can progress to a maculopapular rash, vomiting, diarrhea, and eventually shock and multi-organ failure. The
Marburg is deadly and poses challenges and increased risk to health care workers, which makes the recent outbreak in Uganda that much more concerning.
The latest reports have indicated that
Contact tracing for this outbreak has been significant and includes upwards of 200 people. Currently, the biggest concerns are the high volume of contacts and that the most recent deceased patient had previously traveled across the border to western Kenya to visit 2 traditional healers. This could push the outbreak into the neighboring country. Public health officials in Kenya have been notified and are maintaining surveillance for potential cases.
Given the high fatality rate of Marburg and its ease of transmission through body fluids, control and prevention measures are vital. WHO reports that it will continue to provide up-to-date case counts and information; however, the current efforts to perform contact tracing are complicated by the rural areas and reported resistance by some community members.
Contagion® will continue to track this outbreak on the
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.



























































